Report
Valens Research

STZ - Embedded Expectations Analysis - 2020 03 17

 Constellation Brands, Inc. (STZ:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) Earnings, with a 14.4x Uniform P/E. At these levels, the market has bearish expectations for the firm, but management is confident about their brands, volume growth, and market trends

 Specifically, management is confident that Pacifico had double-digit depletion growth, Familiar will be an important product in specific geographical regions, and that they remain bullish on the future of Corona Premier. Moreover, they are confident that they will see continued acceleration in the Refresca franchise, their Wine & Spirits segment outperformed expectations in Q3, and that their volume growth solidifies their position as a leader in the high-end US beer business. Furthermore, they are confident that Canopy established over 35% share in Alberta, which is Canada's most developed recreational cannabis market, and that Nelson's Green Brier continues to innovate and leverage its existing success. They are also confident that they benefitted from consumer trade up trends and favorable margin trends, targeted a marketing spend of 9.5%-10% of net sales, and their free cash flow improvement was a result of strong operating cash flow
Underlying
Constellation Brands Inc. Class A

Constellation Brands is an international beverage alcohol company. The company is a producer and marketer of beer, wine and spirits with operations in the U.S., Mexico, New Zealand, Italy and Canada. The company has two segments: Beer, in which the company is engaged in the U.S. beer market that includes the imported, craft, domestic super premium, and alternative beverage alcohol categories and it has the right to import, market and sell these Mexican beer brands in the U.S.; and Wine and Spirits, in which its wine portfolio is supported by grapes purchased from independent growers, primarily in the U.S., New Zealand and Chile, and vineyard holdings in the U.S., New Zealand and Italy.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch